Product Launch (Blog)

Nov, 01 2021

Europe Bacteriophages Therapy Market is Growing with a CAGR of 5.1% in the Forecast Period of 2021 to 2028

The Europe Bacteriophages Therapy Market is growing due to factors such as the rising incidence of antibiotic-resistant infections and increasing research and development activities. Moreover, the increased government funding and technological advancements have propelled the demand of the bacteriophages therapy market. However, the high cost associated with the therapy may hamper the market growth.

Europe Bacteriophages Therapy Market Scenario                     

According to Data Bridge Market Research, the market for bacteriophages therapy is growing Europely with market leaders such as Microgen, which accounts for an estimated market share of approximately 73.48%, followed by Fixed-Phage Limited estimated market share of 14.92%, and MICREOS estimated market share of 8.39%. The companies have gained outstanding sales by providing bacteriophages therapy. 

  • In October 2018, Microgen announced that Russian Bacteriophages are used in prevention of emergency infections. The company further added that over 3,000 products have beEurope Bacteriophages Therapy Marketen delivered to Kuban. This has helped the company to earn more revenue.
  • In March 2021, Fixed-Phage Limited announced that the company has accelerated Fixed Phage fight against damaging bacteria. The company further added that they have received a financial help worth USD 286.08 million from its investors. This has helped the company to accelerate the research without facing any financial barrier.

  • In March 2019, MICROES announced that the company has secured fund worth USD 33.60 million to accelerate the development of its endolysin technology, set to replace antibiotics. This has helped the company to open a new therapeutic window for treatment of chronic inflammatory conditions in the market

Trends Impacting the Market

Now the question is which other regions Microgen, Fixed-Phage Limited, MICREOS. are targeting? Data Bridge Market Research has forecasted a large growth in the Asia Pacific Europe bacteriophages therapy market and the market leaders targeting Georgia and Russia to be their next pocket revenue for 2021.

The Europe bacteriophages therapy market is becoming more competitive every year with companies like ATCC, Phagelux, Inc, LOCUS BIOSCIENCES, INC., among others which are the market leaders for bacteriophages therapy.

 The data bridge market research new reports highlight the significant growth factors and opportunities in the Europe bacteriophages therapy market.        

For more analysis on the Europe bacteriophages therapy market, request a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-bacteriophages-therapy-market

Latest Market Developments in 2021

  • In October 2018, Microgen announced that Russian Bacteriophages are used in prevention of emergency infections. The company further added that over 3,000 products have been delivered to Kuban. This has helped the company to earn more revenue.
  • In March 2020, Fixed-Phage Limited announced its collaboration with Carus Animal Health. The aim of collaboration is to identify, evolve and commercialize stable and definite bacteriophages and their application through its patented technology. This collaboration has provided the company with an opportunity to bacteriophages, natural anti-bacterial in stable and commercially-relevant formulations

Scope of Europe bacteriophages therapy  

The Europe bacteriophages therapy market is segmented on the basis of countries into the Georgia, Russia, Belgium, Poland, France, Netherlands, UK, Italy, Germany, Turkey, Switzerland, rest of Europe,

  • All country-based analysis of the Europe bacteriophages therapy market is further analyzed based on maximum granularity into further segmentation. On the basis of target, the bacteriophages therapy market is segmented into Escherichia coli, staphylococcus, streptococcus, pseudomonas, salmonella, and others. On the basis of type, the bacteriophages therapy market is segmented into lytic and lysogenic. On the basis of the base, the bacteriophages therapy market is segmented into sterile broth culture and water-soluble jelly base. On the basis of application, the bacteriophages therapy market is segmented into bacterial dysentery, infection of the skin and nasal mucosa, suppurative skin infections, lung, and pleural infections, post-operative wound infections, others. On the basis of route of administration, the bacteriophages therapy market is segmented into oral, parenteral, dermal, rectal, others. On the basis of end-users, the bacteriophages therapy market is segmented into hospitals, specialty clinics, academic research, and institutes, among others. On the basis of distribution channels, the bacteriophages therapy market is segmented into direct tender, third-party distributors.

To know more about the study https://www.databridgemarketresearch.com/reports/europe-bacteriophages-therapy-market

Key Pointers Covered in Europe Bacteriophages therapy Market Trends and Forecast to 2028

  • Market size
  • Top to bottom market analysis
  • Recent developments for market competitors
  • Recent market value for different countries
  • Market value and overview of bacteriophages therapy market
  • Company profiling of top eight players of bacteriophages therapy market

Key Market Competitors Covered in the Report

  • Armata pharmaceuticals, Inc.
  • LOCUS BIOSCIENCES, INC.  
  • Pherecydes Pharma
  • iNtODEWORLD, Inc.   
  •  EnBiotix, Inc.
  •  Fixed-Phage Limited
  • Microgen
  • MICREOS.
  • ATCC

Above are the key players covered in the report. To know about more and exhaustive list of bacteriophages therapy, contact us  https://www.databridgemarketresearch.com/toc/?dbmr=europe-bacteriophages-therapy-market

Research Methodology: Europe Analytical Laboratory Services Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Healthcare Professionals, Research Laboratories,
  • Supply Side: Manufactures, Service Providers, CRO's

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/


Client Testimonials